Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis

Journal of Neuroimmunology

Volumn 215, Issue 1-2, 2009, Pages 102-107

  Sundström, Peter ^a   Nyström, Maria ^b   Ruuth, Kristina ^b   Lundgren, Erik ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Autoimmune diseases; Case control studies; EBNA 1; Epstein Barr virus; HLA; Multiple sclerosis

Indexed keywords

AMINO ACID; ANTIBODY; EPITOPE; EPSTEIN BARR VIRUS ANTIGEN; HLA DR ANTIGEN; PEPTIDE;

ADOLESCENT; ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; BASE SEQUENCE; CASE-CONTROL STUDIES; COHORT STUDIES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RISK FACTORS;

EID: 70349730272     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.08.004     Document Type: Article

References (42)

1. Alexander F.E., Jarrett R.F., Lawrence D., Armstrong A.A., Freeland J., Gokhale D.A., Kane E., Taylor G.M., Wright D.H., and Cartwright R.A. Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents. Br. J. Cancer 82 (2000) 1117-1121
2. Alotaibi S., Kennedy J., Tellier R., Stephens D., and Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. Jama 291 (2004) 1875-1879
3. Ascherio A., and Munger K.L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol. 61 (2007) 288-299
4. Ascherio A., Munger K.L., Lennette E.T., Spiegelman D., Hernan M.A., Olek M.J., Hankinson S.E., and Hunter D.J. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. Jama 286 (2001) 3083-3088
5. Balandraud N., Meynard J.B., Auger I., Sovran H., Mugnier B., Reviron D., Roudier J., and Roudier C. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum. 48 (2003) 1223-1228
6. Blaschke S., Schwarz G., Moneke D., Binder L., Muller G., and Reuss-Borst M. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. J. Rheumatol. 27 (2000) 866-873
7. Bray P.F., Luka J., Culp K.W., and Schlight J.P. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 42 (1992) 1798-1804
8. Cepok S., Zhou D., Srivastava R., Nessler S., Stei S., Bussow K., Sommer N., and Hemmer B. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J. Clin. Invest. 115 (2005) 1352-1360
9. De Jager P.L., Simon K.C., Munger K.L., Rioux J.D., Hafler D.A., and Ascherio A. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 70 (2008) 1113-1118
10. DeLorenze G.N., Munger K.L., Lennette E.T., Orentreich N., Vogelman J.H., and Ascherio A. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch. Neurol. 63 (2006) 839-844
11. Dyment D.A., Ebers G.C., and Sadovnick A.D. Genetics of multiple sclerosis. Lancet Neurol. 3 (2004) 104-110
12. EMBL. Protein Expression and Purification Facility (2001)
13. Fox R., Sportsman R., Rhodes G., Luka J., Pearson G., and Vaughan J. Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen. J. Clin. Invest. 77 (1986) 1539-1547
14. Graham R.R., Ortmann W., Rodine P., Espe K., Langefeld C., Lange E., Williams A., Beck S., Kyogoku C., Moser K., Gaffney P., Gregersen P.K., Criswell L.A., Harley J.B., and Behrens T.W. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur. J. Hum. Genet. 15 (2007) 823-830
15. Gross A.J., Hochberg D., Rand W.M., and Thorley-Lawson D.A. EBV and systemic lupus erythematosus: a new perspective. J. Immunol. 174 (2005) 6599-6607
16. Haan K.M., and Longnecker R. Coreceptor restriction within the HLA-DQ locus for Epstein-Barr virus infection. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 9252-9257
17. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., Pericak-Vance M.A., Gregory S.G., Rioux J.D., McCauley J.L., Haines J.L., Barcellos L.F., Cree B., Oksenberg J.R., and Hauser S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357 (2007) 851-862
18. Hinderer W., Horn J., Nebel-Schickel H., Vornhagen R., Sonneborn H.H., and Wolf H. Serodiagnosis of Epstein-Barr virus infection: time for new generation assays provided by recombinant DNA technology. Biotest Bull. 4 (1990) 141-146
19. Levin L.I., Munger K.L., Rubertone M.V., Peck C.A., Lennette E.T., Spiegelman D., and Ascherio A. Multiple sclerosis and Epstein-Barr virus. Jama 289 (2003) 1533-1536
20. Lunemann J.D., Edwards N., Muraro P.A., Hayashi S., Cohen J.I., Munz C., and Martin R. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 129 (2006) 1493-1506
21. Lunemann J.D., Jelcic I., Roberts S., Lutterotti A., Tackenberg B., Martin R., and Munz C. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J. Exp. Med. 205 (2008) 1763-1773
22. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Puopolo M., Reynolds R., and Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130 (2007) 1089-1104
23. McAulay K.A., Higgins C.D., Macsween K.F., Lake A., Jarrett R.F., Robertson F.L., Williams H., and Crawford D.H. HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J. Clin. Invest. 117 (2007) 3042-3048
24. McClain M.T., Rapp E.C., Harley J.B., and James J.A. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. J. Med. Virol. 70 (2003) 253-257
25. McClain M.T., Heinlen L.D., Dennis G.J., Roebuck J., Harley J.B., and James J.A. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat. Med. 11 (2005) 85-89
26. McClain M.T., Poole B.D., Bruner B.F., Kaufman K.M., Harley J.B., and James J.A. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis Rheum. 54 (2006) 360-368
27. Munz C. Epstein-Barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target. J. Exp. Med. 199 (2004) 1301-1304
28. Ousman S.S., Tomooka B.H., van Noort J.M., Wawrousek E.F., O'Conner K., Hafler D.A., Sobel R.A., Robinson W.H., and Steinman L. Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature 448 (2007) 474-479
29. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., and Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13 (1983) 227-231
30. Rand K.H., Houck H., Denslow N.D., and Heilman K.M. Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 65 (1998) 48-55
31. Rickinson A.B., and Kieff E. Epstein-Barr virus. In: Fields B.N., Knipe D.M., Howley P.M., et al. (Eds). Fields Virology (1996), Lippincott - Raven Publishers, Philadelphia
32. Schmauss C., and Lerner M.R. The closely related small nuclear ribonucleoprotein polypeptides N and B/B′ are distinguishable by antibodies as well as by differences in their mRNAs and gene structures. J. Biol. Chem. 265 (1990) 10733-10739
33. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., Andreoni L., Trivedi P., Salvetti M., Faggioni A., and Aloisi F. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 204 (2007) 2899-2912
34. Sharipo A., Imreh M., Leonchiks A., Imreh S., and Masucci M.G. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis. Nat. Med. 4 (1998) 939-944
35. Sumaya C.V., Myers L.W., and Ellison G.W. Epstein-Barr virus antibodies in multiple sclerosis. Arch. Neurol. 37 (1980) 94-96
36. Sundstrom P., Nystrom L., and Forsgren L. Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Vasterbotten County in northern Sweden. J. Neurol. Neurosurg. Psychiatry 74 (2003) 29-32
37. Sundstrom P., Juto P., Wadell G., Hallmans G., Svenningsson A., Nystrom L., Dillner J., and Forsgren L. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 62 (2004) 2277-2282
38. Sundstrom P., Nystrom L., Jidell E., and Hallmans G. EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study. Mult. Scler. 14 (2008) 1120-1122
39. Thacker E.L., Mirzaei F., and Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann. Neurol. 59 (2006) 499-503
40. van Noort J.M., van Sechel A.C., Bajramovic J.J., el Ouagmiri M., Polman C.H., Lassmann H., and Ravid R. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 375 (1995) 798-801
41. van Sechel A.C., Bajramovic J.J., van Stipdonk M.J., Persoon-Deen C., Geutskens S.B., and van Noort J.M. EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. J. Immunol. 162 (1999) 129-135
42. Wagner H.J., Munger K.L., and Ascherio A. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis. Eur. J. Neurol. 11 (2004) 833-834